| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |